| Dr David Allan Wilkinson, | |
|
1024 Central Park Dr, Steamboat Springs, CO 80487-8813 | |
| (970) 879-1322 | |
| (970) 870-1223 |
| Full Name | Dr David Allan Wilkinson |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1024 Central Park Dr, Steamboat Springs, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063516680 | NPI | - | NPPES |
| 01251453 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | G25145 (Colorado) | Primary |
| Entity Name | Yampa Valley Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790787307 PECOS PAC ID: 5890685689 Enrollment ID: O20040316001301 |
News Archive
Researchers from the University of Liverpool in collaboration with Public Health England have been investigating new ways to identify drugs that could be used to treat Ebola virus infection.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX in the EU, announced today that it has injected the first patient in its placebo-controlled Phase 2 clinical trial of CCH for the treatment of lipoma.
Previous reports from the group at Mayo Clinic have demonstrated that B7-H1 expression by renal cell carcinoma (RCC) is a marker of poor prognosis in both localized and metastatic RCC.
The West Australian Department of Health has issued an alert following notification of five cases of measles in Western Australia over the Easter period.
Travelers who have had a booster or a third dose will be able to demonstrate their vaccine status through the NHS COVID Pass from Friday 19 November.
› Verified 4 days ago
| Entity Name | Orthopaedics Of Steamboat Springs Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073538401 PECOS PAC ID: 9335119023 Enrollment ID: O20040729000867 |
News Archive
Researchers from the University of Liverpool in collaboration with Public Health England have been investigating new ways to identify drugs that could be used to treat Ebola virus infection.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX in the EU, announced today that it has injected the first patient in its placebo-controlled Phase 2 clinical trial of CCH for the treatment of lipoma.
Previous reports from the group at Mayo Clinic have demonstrated that B7-H1 expression by renal cell carcinoma (RCC) is a marker of poor prognosis in both localized and metastatic RCC.
The West Australian Department of Health has issued an alert following notification of five cases of measles in Western Australia over the Easter period.
Travelers who have had a booster or a third dose will be able to demonstrate their vaccine status through the NHS COVID Pass from Friday 19 November.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Allan Wilkinson, 1024 Central Park Dr, Steamboat Springs, CO 80487-8813 Ph: (970) 879-1322 | Dr David Allan Wilkinson, 1024 Central Park Dr, Steamboat Springs, CO 80487-8813 Ph: (970) 879-1322 |
News Archive
Researchers from the University of Liverpool in collaboration with Public Health England have been investigating new ways to identify drugs that could be used to treat Ebola virus infection.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX in the EU, announced today that it has injected the first patient in its placebo-controlled Phase 2 clinical trial of CCH for the treatment of lipoma.
Previous reports from the group at Mayo Clinic have demonstrated that B7-H1 expression by renal cell carcinoma (RCC) is a marker of poor prognosis in both localized and metastatic RCC.
The West Australian Department of Health has issued an alert following notification of five cases of measles in Western Australia over the Easter period.
Travelers who have had a booster or a third dose will be able to demonstrate their vaccine status through the NHS COVID Pass from Friday 19 November.
› Verified 4 days ago
David John Cionni, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1024 Central Pk Dr, Steamboat Springs, CO 80487 Phone: 970-870-1040 Fax: 970-870-1164 | |
Dr. Laura Ann Sehnert, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1024 Central Park Dr, Steamboat Springs, CO 80487 Phone: 970-870-1040 | |
Laila Wilber Powers, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1024 Central Park Drive, Steamboat Springs, CO 80487 Phone: 970-879-1322 Fax: 970-870-1223 | |
Dr. Nathan Reed Anderson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1024 Central Park Drive, Steamboat Springs, CO 80487 Phone: 970-879-1322 Fax: 970-870-1223 | |
Susan Watson, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1024 Central Park Dr, Yvmc Ed, Steamboat Springs, CO 80487 Phone: 970-870-1040 | |
Jeanne Carolyn Fitzsimmons, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1024 Central Park Drive, Steamboat Springs, CO 80487 Phone: 970-879-1322 Fax: 970-870-1223 |